Recent and Future Advances in Reducing HPV-associated Cancers by Vaccination and Screening
Click for RECORDING Passcode: 70^.AycJ
Doug Lowy, MD, Principal Deputy Director │ National Cancer Institute
The presentation provides an update on the induction of herd immunity by HPV vaccination and its implications for reducing the risk of HPV-associated cancers and for changing cervical cancer screening guidelines. Clinical research whose goal is to enable wider dissemination of vaccination and screening was also described.
via Zoom on Friday, January 15, 2021 (Presentation was recorded)
PLEASE CONTACT Jennifer Smith with questions